Missing CAPA Costs J&J $25 Million In Investigation Sparked By OTC Recalls
This article was originally published in The Tan Sheet
Executive Summary
J&J/McNeil enter a guilty plea in federal court to a misdemeanor charge of distributing adulterated drugs and agree to pay a criminal fine of $20 million and forfeit $5 million. McNeil has submitted to FDA experts’ certifications of remediation processes being complete at its three facilities subject to a consent decree.
You may also be interested in...
J&J Settlement With States Not Likely To Be Precedent In OTC Space
J&J's agreement with 42 states and Washington, D.C. is its latest cost from widespread GMP problems that prompted recalls and led to a 2011 FDA consent decree. But the unusual combination of factors suggest more such state actions are unlikely to follow.
J&J Settlement With States Not Likely To Be Precedent In OTC Space
J&J's agreement with 42 states and Washington, D.C. is its latest cost from widespread GMP problems that prompted recalls and led to a 2011 FDA consent decree. But the unusual combination of factors suggest more such state actions are unlikely to follow.
Tracking Federal Agencies’ Enforcement In Supplement Space
““The Tan Sheet” provides links to previous articles on many of the enforcements DoJ announced from its year-long sweep.